AB2 Bio Ltd.   Report issue

For profit Phase 3
Founded: Ecublens Switzerland (2010)

Organization Overview

First Clinical Trial
2015
NCT02398435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

AB2 Bio Ltd.